Keith R. Walley

St. Paul's Hospital
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 160 publications

Correction: Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Correction: Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Journal: Scientific reports

Published: February 17, 2026

Causal effects of serum testosterone on septic shock mortality: a Mendelian randomization study.

Causal effects of serum testosterone on septic shock mortality: a Mendelian randomization study.

Journal: Critical care (London, England)

Published: November 28, 2025

Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis.

Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis.

Journal: Stem cells translational medicine

Published: October 28, 2025

Obesity- and Lipid-Related Traits May Causally Contribute to Sepsis-Associated Acute Kidney Injury.

Obesity- and Lipid-Related Traits May Causally Contribute to Sepsis-Associated Acute Kidney Injury.

Journal: Critical care medicine

Published: August 14, 2025

Decreased Clearance of Low-Density Lipoprotein Cholesterol is Causally Associated With Increased Mortality of Septic Shock.

Decreased Clearance of Low-Density Lipoprotein Cholesterol is Causally Associated With Increased Mortality of Septic Shock.

Journal: Critical care medicine

Published: August 04, 2025

Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired Pneumonia.

Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired Pneumonia.

Journal: Critical care explorations

Published: May 30, 2025

Low apolipoprotein A-II levels causally contribute to increased mortality in septic shock.

Low apolipoprotein A-II levels causally contribute to increased mortality in septic shock.

Journal: Journal of intensive care

Published: December 12, 2024

Lessons From the LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P) Trial.

Lessons From the LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P) Trial.

Journal: Critical care medicine

Published: July 15, 2024

Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Journal: Scientific reports

Published: July 09, 2024

Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Plasma apolipoprotein A-I is a causal protective factor in sepsis.

Journal: Scientific reports

Published: July 09, 2024

Community versus academic hospital community-acquired pneumonia patients: a nested cohort study.

Community versus academic hospital community-acquired pneumonia patients: a nested cohort study.

Journal: Pneumonia (Nathan Qld.)

Published: June 19, 2024

Cardiovascular risk and subclinical atherosclerosis in first-degree relatives of patients with premature cardiovascular disease.

Cardiovascular risk and subclinical atherosclerosis in first-degree relatives of patients with premature cardiovascular disease.

Journal: American journal of preventive cardiology

Published: April 03, 2024

Showing 1-12 of 160

Last Updated: 09/26/2026